Oncogenic targeting of BRM drives malignancy through C/EBP?-dependent induction of a5 integrin.
Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM. Oncogenic targeting of BRM drives malignancy through C/EBP?-dependent induction of a5 integrin. Oncogene. 2014 May 08; 33(19):2441-53.